Insulin

Pharmaceutical behemoth Eli Lilly will slash the cost of its popular insulin products, relieving some of the financial burden on millions of Americans with diabetes.The company said Tuesday that it will cut prices of its Humalog and Humulin…

By Jen Christensen | CNN Eli Lilly announced Wednesday a series of price cuts that would lower the price of the most commonly used forms of its insulin 70% and said it will automatically cap out-of-pocket insulin costs at $35 for people who…

The drugmaker Eli Lilly is cutting prices for its insulin and capping costs at $35 per month, the company said Wednesday.  Out-of-pocket costs at participating retail pharmacies will max out at $35 for patients with commercial…

Eli Lilly plans to cut prices on its most commonly prescribed insulin products and will also cap customers' out-of-pocket costs at $35 a month for those with commercial insurance who use its insulin. The…

Patient activists have managed to turn U.S. insulin prices into a kitchen table issue in part through their use of Twitter. ▶ Watch Video: Caravan of Americans battling…

Hannah Crabtree got active on Twitter in 2016 to find more people like herself: those with Type 1 diabetes who'd hacked their insulin pumps to automatically adjust the amount of insulin delivered.Soon, though, Crabtree found a more…

Colorado’s insulin cost cap can save people with diabetes hundreds of dollars a month, but some patients have reported confusion about how to take advantage of it. A law passed in 2019 and expanded in 2021 limits the out-of-pocket cost of…

Diabetics are turning to the black market to get hold of vital insulin amid soaring costs blamed on ever-more complex supply chains.On average, insulin prices have more than tripled over the past decade to $98.70 per vial, with Americans…

PTI | | Posted by Parmita Uniyal, Boston Higher vitamin D intake may be associated with a lower risk of developing type 2 diabetes in adults with prediabetes, a review of clinical trials has found. Vitamin D is a fat-soluble vitamin…

By Ana B. Ibarra | CalMatters As many diabetics across the Golden State struggle with insulin costs, California’s efforts to make the medication more affordable have yet to yield results. This year, lawmakers will revisit legislation that…